MedPath

Noile-Immune Biotech, Inc.

Noile-Immune Biotech, Inc. logo
🇯🇵Japan
Ownership
Public
Established
2015-04-01
Employees
28
Market Cap
-
Website
http://www.noile-immune.com

Study of NIB101 in Participants With Advanced Solid Tumors

Phase 1
Terminated
Conditions
Solid Tumor
Interventions
First Posted Date
2022-01-14
Last Posted Date
2025-05-23
Lead Sponsor
Noile-Immune Biotech, Inc
Target Recruit Count
3
Registration Number
NCT05192174
Locations
🇯🇵

National Cancer Center Hospital East, Kashiwa, Chiba, Japan

🇯🇵

National Cancer Center Hospital, Chuo Ku, Tokyo, Japan

© Copyright 2025. All Rights Reserved by MedPath